Romy-500 Injection 1 ml
About Romy-500 Injection 1 ml
Romy-500 Injection 1 ml belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.
Romy-500 Injection 1 ml contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romy-500 Injection 1 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy-500 Injection 1 ml helps treat immune thrombocytopenia effectively.
Romy-500 Injection 1 ml will be administered by the healthcare professional. In some cases, Romy-500 Injection 1 ml may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Notify your doctor if you have allergic reactions to Romy-500 Injection 1 ml or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Romy-500 Injection 1 ml is not recommended during pregnancy unless indicated by the doctor. Romy-500 Injection 1 ml may make you dizzy; hence drive or operate machinery only when you are alert. Romy-500 Injection 1 ml is not recommended for use during breastfeeding.
Uses of Romy-500 Injection 1 ml
Medicinal Benefits
Romy-500 Injection 1 ml contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Romy-500 Injection 1 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy-500 Injection 1 ml helps treat immune thrombocytopenia effectively.
Directions for Use
Storage
Side Effects of Romy-500 Injection 1 ml
Drug Warnings
Before beginning Romy-500 Injection 1 ml, notify your doctor if you have had any allergic reactions to Romy-500 Injection 1 ml or any other medications. You must notify your doctor if you have blood or bone marrow cancer (leukaemia), bleeding or clotting disorders, heart, kidney, or liver problems. Romy-500 Injection 1 ml is not recommended during pregnancy unless indicated by the doctor. Romy-500 Injection 1 ml may make you dizzy hence do not attempt to drive or operate machinery until you are physically stable and mentally alert. Romy-500 Injection 1 ml should never be used to normalize platelet counts; Romy-500 Injection 1 ml should only be used in ITP patients whose thrombocytopenia and clinical condition increase the risk of bleeding. Romy-500 Injection 1 ml is not recommended for use during breastfeeding.
Drug Interactions
Drug-Drug Interactions: Romy-500 Injection 1 ml may interact with anti-cancer medication (e.g. carfilzomib, ibritumomab) and medication used to treat myasthenia gravis (e.g. efgartigimod alfa).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Romy-500 Injection 1 ml may interact with disease conditions like leukaemia, liver or kidney impairment.
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Disease/Condition Glossary
Immune thrombocytopenia: It is an immune disorder characterised by low platelet counts and abnormal blood clotting. It happens when the immune system destroys its own platelets by mistake. Immune thrombocytopenia symptoms include easy bruising, bleeding from the gums and nose, blood in the urine and stools, heavy menstruation, and pinpoint-sized reddish-purple patches on the lower thighs.